Jump to content
  • 0

Bristol-Myers shares down nearly 2 percent. Can it recover soon?


Micheal Ben
 Share

Question

1 answer to this question

Recommended Posts

  • 0

The shares of Bristol-Myers Squibb plunged after the company urged its shareholders to support its planned $74 billion takeover of Celgene Corp. The drug manufacturer believes the takeover is the best course of action but the company shareholders are rejecting the proposals. Some shareholders publicly opposed the deal and that does not do anything good for Bristol Myers. The low correlation between the management and shareholders doesn't inspire investor confidence and the stock could plunge further very soon. 

Link to comment
Share on other sites

Join the conversation

You can post now and register later. To reply to this question, sign in or create a new account.

Guest
Reply to this question

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

 Share

×
×
  • Create New...